Maravai Lifesciences Holdings (MRVI) Other financing activities (2020 - 2026)

Maravai Lifesciences Holdings' Other financing activities history runs 5 years deep, the most recent figure standing at -$3.9 million for Q1 2026.

• In Q1 2026, Other financing activities fell 9.21% year-over-year to -$3.9 million; the TTM figure through Mar 2026 stood at -$326000.0 (up 93.03% YoY), while the FY2024 annual figure was $1.2 million, down 79.88% from the prior year.
• Other financing activities was -$3.9 million for Q1 2026 at Maravai Lifesciences Holdings, down from -$1.4 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.9 million in Q2 2025 to a low of -$5.8 million in Q4 2024.
• Historically, Other financing activities has averaged $295250.0 across 4 years, with a median of $1.7 million in 2023.
• Biggest YoY gain for Other financing activities was 383.33% in 2024; the steepest drop was 350.58% in 2024.
• A 4-year view of Other financing activities shows it stood at $2.3 million in 2023, then slumped by 350.58% to -$5.8 million in 2024, then soared by 76.38% to -$1.4 million in 2025, then plunged by 181.16% to -$3.9 million in 2026.
• The last three Other financing activities figures came in at -$3.9 million (Q1 2026), -$1.4 million (Q4 2025), and $4.9 million (Q2 2025), per Business Quant data.